Flow Rate Effect Respimat Inhaler Versus a Metered Dose Inhaler Using Berodual in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2005
The objective of this trial is to compare the total and regional deposition of aerosol in the lungs and oropharynx of patients with COPD at 3 different inspiratory flow rates following inhalation of Berodual delivered via the Respimat inhaler and Berodual? delivered via an HFA-metered dose inhaler.
Epistemonikos ID: 6fae845625386c2023b411f3d9281a730ca32366
First added on: May 04, 2024